Production (Stage)
Pharming Group N.V.
PHGUF
$1.19
$0.18518.50%
OTC PK
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Net Income | -- | -13.33M | -10.79M | -10.55M | |
| Total Depreciation and Amortization | -- | 10.29M | 13.74M | 10.13M | |
| Total Amortization of Deferred Charges | -- | 884.00K | 884.00K | 884.00K | |
| Total Other Non-Cash Items | -- | 12.67M | -199.00K | -802.00K | |
| Change in Net Operating Assets | -- | -16.28M | -5.80M | -16.96M | |
| Cash from Operations | -- | -5.76M | -2.16M | -17.30M | |
| Capital Expenditure | -- | -745.00K | -1.30M | -1.44M | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -24.33M | -127.21M | -127.95M | |
| Cash from Investing | -- | -25.08M | -128.51M | -129.39M | |
| Total Debt Issued | -- | 104.80M | -- | -- | |
| Total Debt Repaid | -- | -137.92M | -3.49M | -3.77M | |
| Issuance of Common Stock | -- | 12.26M | 9.68M | 9.49M | |
| Repurchase of Common Stock | -- | -- | -695.00K | -695.00K | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -5.70M | -6.38M | -6.07M | |
| Cash from Financing | -- | -26.56M | -880.00K | -1.04M | |
| Foreign Exchange rate Adjustments | -- | -488.00K | -1.34M | 2.13M | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | -57.88M | -132.89M | -145.60M | |